Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 9/20 | 0.40 |
| ▸ | CTSL | P07711 | 8/20 | 0.40 |
| ▸ | CTSV | O60911 | 2/20 | 0.40 |
| ▸ | CTSK | P43235 | 10/20 | 0.37 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.36 |
| ▸ | HTRA1 | Q92743 | 2/20 | 0.33 |
| ▸ | F2RL1 | P55085 | 2/20 | 0.32 |
| ▸ | F12 | P00748 | 1/20 | 0.31 |
| ▸ | GCK | P35557 | 1/20 | 0.31 |
| ▸ | CTSB | P07858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4047616 | 0.90 | CTSL (0.46) | CTSSCTSLCTSVCTSKCTSB | |
| SCHEMBL4047693 | 0.90 | CTSK (0.40) | CTSSCTSLCTSVCTSKCTSB | |
| SCHEMBL4041785 | 0.89 | PREP (0.35) | CTSSCTSLCTSK | |
| SCHEMBL4043853 | 0.89 | CTSK (0.37) | CTSSCTSLCTSK | |
| SCHEMBL4041994 | 0.89 | CTSS (0.39) | CTSSCTSLCTSVCTSKUSP30 | |
| SCHEMBL4041369 | 0.88 | CTSS (0.42) | CTSSCTSLCTSVCTSKUSP30 | |
| SCHEMBL4043551 | 0.87 | CTSL (0.41) | CTSSCTSLCTSVCTSKHTRA1 | |
| SCHEMBL4049892 | 0.84 | CTSS (0.37) | CTSSCTSLCTSVCTSKUSP30 | |
| SCHEMBL4043817 | 0.84 | CTSL (0.39) | CTSSCTSLCTSVCTSKHTRA1 | |
| SCHEMBL4042622 | 0.82 | CTSS (0.40) | CTSSCTSLCTSVCTSKF2RL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1546150-B1 | PYRROLE DERIVATIVES AS INHIBITORS OF CYTEINE PROTEASES | AMURA THERAPEUTICS LTD (GB) | 2009-03-04 | — | — | EP | claimed |